Company Filing History:
Years Active: 1999-2012
Title: Ulagaraj Selvaraj: Innovator in Microparticle Technology
Introduction
Ulagaraj Selvaraj is a notable inventor based in Apex, NC (US), recognized for his contributions to the field of microparticle technology. With a total of 4 patents to his name, Selvaraj has made significant advancements in the preparation and application of microparticles, particularly those involving water-insoluble substances.
Latest Patents
Selvaraj's latest patents focus on the development of microparticles of water-insoluble substances. One of his inventions provides a composition that includes microparticles of a water-insoluble or poorly soluble compound, at least one phospholipid, and at least one surfactant. This composition is produced by applying energy to a mixture of these components, resulting in microparticles that are smaller than those produced by previously known methods. These microparticles exhibit advantageous properties, including remarkable resistance to particle size growth during storage. Another patent details a method for preparing pharmaceutical compositions containing cyclosporin microparticles. This method involves applying energy to cyclosporin particles in the presence of phospholipid and surface modifiers, yielding particles that are significantly smaller than those produced without the modifiers.
Career Highlights
Throughout his career, Ulagaraj Selvaraj has worked with various organizations, including Research Triangle Pharmaceuticals. His innovative work has contributed to advancements in pharmaceutical formulations and delivery systems.
Collaborations
Selvaraj has collaborated with notable professionals in his field, including Indu Parikh and John P Witham. These collaborations have further enhanced the impact of his inventions and research.
Conclusion
Ulagaraj Selvaraj stands out as a prominent inventor in the realm of microparticle technology. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical science and improving drug delivery systems.